To investigate the clinical safety and efficacy of transurethral 1064nm super pulse laser enucleation of the prostate for benign prostatic hyperplasia (BPH).

From August 2018 to August 2019, 82 patients with BPH were hospitalized in urology deparrtment of our hospital. The average volume of prostate was (73±25) ml (41-159) ml. The surgical envelope of the prostate was found at 5 o'clock on the left side of the outer sphincter from the proximal side of the outer sphincter. Vaporization and hemostasis were used by 1064 nm super pulse laser. After whole enucleation or lobulating enucleation, glandular specimens were pushed into bladder cavity. All patients were followed up for 3 months.

The average time of enucleation of glands was (36±10) min(24-61) min, the average time of tissue crushing was (11±6) min (5-51) min, the average mass of removed glandular tissue was (60±21) g (31-124) g and the average time of operation was (80±28) min (55-148) min, the average hemoglobin decreased was (17±8) g/L (3-34) g/L. None of the patients received blood transfusion. Catheter had been indwelling for (5.3±1.5)days. After 3 months of follow-up, IPSS, QOL, Qmax and RUV were significantly better than those before operation (P<0.01). On the first day after pulling out the catheter, 7 patients had temporary urinary incontinence, 4 cases recovered after 1 week of pelvic floor muscle exercise, 2 cases recovered after 2 weeks, all recovered after 4 weeks. No patient had urethral stricture and bladder neck contracture.

1 064 nm super pulse laser has a good hemostatic and tissue vaporization cutting effect, transurethral enucleation of the prostate can effectively remove hyperplastic glands, it is a safe and effective surgical procedure for BPH.